UFP TECHNOLOGIES INC (UFPT)

US9026731029 - Common Stock

222.59  +9.34 (+4.38%)

After market: 222.59 0 (0%)

Fundamental Rating

6

UFPT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making UFPT a very profitable company, without any liquidiy or solvency issues. UFPT is not valued too expensively and it also shows a decent growth rate. This makes UFPT very considerable for quality investing!



8

1. Profitability

1.1 Basic Checks

UFPT had positive earnings in the past year.
UFPT had a positive operating cash flow in the past year.
UFPT had positive earnings in each of the past 5 years.
UFPT had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

UFPT has a better Return On Assets (11.11%) than 94.27% of its industry peers.
With an excellent Return On Equity value of 15.70%, UFPT belongs to the best of the industry, outperforming 91.15% of the companies in the same industry.
UFPT has a Return On Invested Capital of 13.56%. This is amongst the best in the industry. UFPT outperforms 95.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UFPT is in line with the industry average of 8.50%.
The last Return On Invested Capital (13.56%) for UFPT is above the 3 year average (9.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.11%
ROE 15.7%
ROIC 13.56%
ROA(3y)8.98%
ROA(5y)8.8%
ROE(3y)13.83%
ROE(5y)12.26%
ROIC(3y)9.4%
ROIC(5y)9.46%

1.3 Margins

With an excellent Profit Margin value of 11.22%, UFPT belongs to the best of the industry, outperforming 86.46% of the companies in the same industry.
In the last couple of years the Profit Margin of UFPT has grown nicely.
Looking at the Operating Margin, with a value of 14.41%, UFPT belongs to the top of the industry, outperforming 86.46% of the companies in the same industry.
UFPT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 28.05%, UFPT is doing worse than 75.00% of the companies in the same industry.
UFPT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.41%
PM (TTM) 11.22%
GM 28.05%
OM growth 3Y14.65%
OM growth 5Y5.97%
PM growth 3Y14.56%
PM growth 5Y8.39%
GM growth 3Y4.03%
GM growth 5Y2%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UFPT is creating some value.
The number of shares outstanding for UFPT has been increased compared to 1 year ago.
The number of shares outstanding for UFPT has been increased compared to 5 years ago.
The debt/assets ratio for UFPT has been reduced compared to a year ago.

2.2 Solvency

UFPT has an Altman-Z score of 10.86. This indicates that UFPT is financially healthy and has little risk of bankruptcy at the moment.
UFPT has a better Altman-Z score (10.86) than 88.54% of its industry peers.
The Debt to FCF ratio of UFPT is 1.04, which is an excellent value as it means it would take UFPT, only 1.04 years of fcf income to pay off all of its debts.
UFPT's Debt to FCF ratio of 1.04 is amongst the best of the industry. UFPT outperforms 91.15% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that UFPT is not too dependend on debt financing.
UFPT has a Debt to Equity ratio (0.10) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.04
Altman-Z 10.86
ROIC/WACC1.35
WACC10.08%

2.3 Liquidity

UFPT has a Current Ratio of 2.48. This indicates that UFPT is financially healthy and has no problem in meeting its short term obligations.
UFPT's Current ratio of 2.48 is on the low side compared to the rest of the industry. UFPT is outperformed by 64.58% of its industry peers.
UFPT has a Quick Ratio of 1.28. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
UFPT has a Quick ratio of 1.28. This is in the lower half of the industry: UFPT underperforms 74.48% of its industry peers.
UFPT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.28

6

3. Growth

3.1 Past

UFPT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.95%.
Measured over the past years, UFPT shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.74% on average per year.
The Revenue has grown by 13.12% in the past year. This is quite good.
UFPT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.00% yearly.
EPS 1Y (TTM)6.95%
EPS 3Y48.68%
EPS 5Y22.74%
EPS growth Q2Q37.27%
Revenue 1Y (TTM)13.12%
Revenue growth 3Y30.65%
Revenue growth 5Y16%
Revenue growth Q2Q11.29%

3.2 Future

The Earnings Per Share is expected to grow by 8.62% on average over the next years. This is quite good.
UFPT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.16% yearly.
EPS Next Y3.39%
EPS Next 2Y8.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.8%
Revenue Next 2Y9.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.05, which means the current valuation is very expensive for UFPT.
Based on the Price/Earnings ratio, UFPT is valued a bit cheaper than 73.96% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.02. UFPT is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 36.80, UFPT can be considered very expensive at the moment.
UFPT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. UFPT is cheaper than 75.52% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, UFPT is valued quite expensively.
Industry RankSector Rank
PE 38.05
Fwd PE 36.8

4.2 Price Multiples

76.04% of the companies in the same industry are more expensive than UFPT, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 79.17% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 55.14
EV/EBITDA 23.97

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of UFPT may justify a higher PE ratio.
PEG (NY)11.21
PEG (5Y)1.67
EPS Next 2Y8.62%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for UFPT!.
Industry RankSector Rank
Dividend Yield N/A

UFP TECHNOLOGIES INC

NASDAQ:UFPT (4/29/2024, 7:00:01 PM)

After market: 222.59 0 (0%)

222.59

+9.34 (+4.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.70B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 38.05
Fwd PE 36.8
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)11.21
PEG (5Y)1.67
Profitability
Industry RankSector Rank
ROA 11.11%
ROE 15.7%
ROCE
ROIC
ROICexc
ROICexgc
OM 14.41%
PM (TTM) 11.22%
GM 28.05%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.48
Quick Ratio 1.28
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)6.95%
EPS 3Y48.68%
EPS 5Y
EPS growth Q2Q
EPS Next Y3.39%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.12%
Revenue growth 3Y30.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y